Zepbound’s greater weight loss is a huge advantage for Eli Lilly, which is competing with Novo Nordisk for a larger share of the weight loss drug market.
Related Posts
Trump targets Washington Post, CBS with long-shot legal actions over Harris coverage, ads
The Donald Trump legal bids against CBS and the Washington Post came days before the election between the GOP nominee and his Democratic rival, Kamala […]
NFL approves sale of minority stake in the Philadelphia Eagles at $8.3 billion value
The National Football league has approved the sale of a minority stake in the Philadelphia Eagles to two family investment groups.
Procter & Gamble earnings beat estimates as shoppers buy more household staples
Procter & Gamble beat quarterly earnings and revenue estimates and also reiterated its fiscal 2025 forecast.